Search

everythinglearnresearchcommunity

for

Search:↓

Both Platelet-Rich Plasma and Minoxidil foam increase hair count in women with hair loss, but Minoxidil is more effective. However, women were more satisfied with Platelet-Rich Plasma treatment.

Low-level laser therapy effectively treats female hair loss, increasing hair count by 51%.

New scale reliably assesses male hair loss with female pattern.

New method measures female hair loss: Female Pattern Hair Loss Severity Index (FPHL-SI).

Understanding the cause of bitemporal hair loss is key to deciding the right treatment.

AI is effective in diagnosing and treating hair disorders, including detecting hair loss and scalp conditions with high accuracy, but it should supplement, not replace, doctor-patient interactions.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

Hair diameter diversity is a key sign for diagnosing and managing male pattern baldness.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

Etanercept is safe and may help improve hidradenitis suppurativa, but more research is needed.

Mutations in the SRD5A3 gene cause a new type of glycosylation disorder by blocking the production of a molecule necessary for protein glycosylation.

Different types of hair loss need specific treatments, and while many classification systems exist, each has its flaws; more research is needed to refine these systems and treatments.

Men with more severe hair loss had a lower risk of schizophrenia, but hair loss and testosterone levels were not linked.

Niacin derivatives may increase hair fullness in women with hair loss.

Advanced male pattern baldness affects the back of the scalp, reducing hair follicles.

WNT7A gene expression is higher in early stages of androgenetic alopecia, showing the role of WNT pathway, apoptosis, and inflammation in the disorder.

The cross beam laser is a useful tool for safely measuring scalp stretchiness to improve hair transplant results.

The hair shedding scale accurately identifies abnormal hair shedding in women with long hair, with grades 5 and 6 indicating excessive shedding.

There may be a link between hair loss and heart disease in women, but more research is needed.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

Ephrins slow down skin and hair follicle cell growth.

Trichotillometry is a reliable method to measure hair strength and assess hair loss treatments.

Treatments for hair loss include hormone modifiers, minoxidil, and hair transplant surgery.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

Hair transplants are highly satisfactory for treating female-pattern hair loss.

A simplified scoring system can effectively diagnose hirsutism in Chinese women of reproductive age.

The article concludes that better diagnosis and management of Polycystic Ovarian Syndrome are needed to improve women's health and prevent related diseases.

Female pattern hair loss greatly affects quality of life, especially in younger patients, those with the condition for a long time, and those with mental health issues. A more comprehensive treatment approach is suggested.

PRP improves hair growth short-term but may need retreatment for long-term results.

Dutasteride injections can help hair growth in androgenic alopecia but need more research for long-term use.